Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive
Read More
experimental
FDA reversals leave investors worrying about the fates of other experimental drugs
Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from
Read More
Moderna says FDA refuses to review its application for experimental flu shot
The Food and Drug Administration has refused to start a review of Moderna’s application for its experimental flu shot, the
Read More